Curis | CRIS - Current Liabilities


Curis reported $14.97M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Alaunos Therapeutics USD 595K 218K Mar/2026
Amgen USD 25.5B 547M Jun/2026
AstraZeneca USD 31.55B 1.02B Jun/2026
Bayer EUR 32.27B 1.19B Jun/2026
Bristol-Myers Squibb USD 18.66B 499M Jun/2026
CSL USD 4.61B 207M Dec/2025
Curis USD 14.97M 898K Mar/2026
Eli Lilly USD 47.74B 11.11B Jun/2026
Exelixis USD 361.93M 9.05M Jun/2026
Gilead Sciences USD 11.02B 1.54B Jun/2026
GlaxoSmithKline GBP 21.53B 895M Jun/2026
Incyte USD 1.31B 177.55M Jun/2026
Merck USD 27.73B 786M Jun/2026
Novartis USD 31.75B 374M Jun/2026
Pfizer USD 32.65B 1.7B Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sanofi EUR 31.93B 1.92B Jun/2026
Takeda JPY 2.76T 335.02B Jun/2026
TG Therapeutics USD 268.49M 81.38M Jun/2026
Verastem USD 66.84M 5.42M Mar/2026